Dermatology Practice Transition Planning

A dermatology practice is more than its collections.

If you are considering a transition, we want to understand what should remain dependable for patients and what a successor would truly need to assume. Dermatology practices can mix medical care, Mohs, cosmetic services, pathology arrangements, and device economics that should not be valued as one undifferentiated stream.

Discuss my dermatology practice

What we would want to understand first

Before suggesting that a sale, successor, affiliation, planned wind-down, or more preparation makes sense, we look at the business facts and the continuity obligations that make your specialty different. Gross collections alone do not answer that question.

What may transfer

Stable medical dermatology demand
Surveillance and recall workflows
Staff and procedural operating protocols

What may still depend on you

Owner-specific cosmetic following
Mohs or pathology relationships
Lasers, injectables, product inventory, and device leases

What we ask for

Medical, Mohs, and cosmetic revenue split
Surveillance and pathology workflows
Device and inventory schedules
Referral and staffing continuity

Where this can lead

Your Workup may point toward preparation for sale, a successor transition, affiliation or merger review, a planned wind-down, or additional documentation before choosing. We show a numeric planning range only when collections, expenses, and estimated replacement physician compensation are available. Separately owned ancillary assets remain separate when relevant.

Keep it business-only

Please share operational, financial, staffing, and aggregate continuity information only. Do not send patient names, appointment-level records, clinical notes, diagnoses, dates of birth, or other identifiable patient data.